| abstract |
The present invention provides compounds of the Formula (la): a stereoisomer, a tautomer or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective inhibitors of factor XIa or dual inhibitors of FXIa and plasma kallikrein. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods for treating thromboembolic and / or inflammatory disorders by use. |